NACT Use Appears to Be Increasing in Less Common Epithelial

Patients with low-grade serous ovarian cancer appear to have worse survival outcomes following treatment with neoadjuvant chemotherapy (NACT).

Related Keywords

United States , , National Cancer Database , End Results , Ovarian Cancer , Enact , Jama Network Open ,